Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke

Toxicology Letters

Volumn 189, Issue 3, 2009, Pages 225-234

  Zheng, Hongao ^a   Liu, Yuening ^a   Huang, Tian ^a   Fang, Zheman ^a   Li, Guishuang ^a   He, Shaoheng ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Chronic obstructive pulmonary disease; Cigarette smoke; Morphometry; Pulmonary function; Rats

Indexed keywords

CARBON MONOXIDE; CIGARETTE SMOKE; MUCIN;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MODEL; ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HYPERPLASIA; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MUCUS SECRETION; NEUTROPHIL COUNT; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; INDICATORS AND REAGENTS; LUNG; MALE; MUCINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RATS; RATS, WISTAR; RESPIRATORY FUNCTION TESTS; SMOKING;

ANIMALIA; RATTUS;

EID: 67650034255     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.06.850     Document Type: Article

References (38)

1. Abdullah L.H., Davis S.W., Burch L., Yamauchi M., Randell S.H., Nettesheim P., and Davis C.W. P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. Biochem. J. 316 (1996) 943-951
2. Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc. Am. Thorac. Soc. 4 (2007) 522-525
3. Agustí A.G., Noguera A., Sauleda J., Sala E., Pons J., and Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur. Respir. J. 21 (2003) 347-360
4. Aikawa T., Shimura S., Sasaki H., Takishima T., Yaegashi H., and Takahashi T. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 140 (1989) 477-482
5. American Thoracic Society, European Respiratory Society, 1999. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am. J. Respir. Crit. Care Med. 159, S1-40.
6. Bracke K.R., D'hulst A.I., Maes T., Moerloose K.B., Demedts I.K., Lebecque S., Joos G.F., and Brusselle G.G. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J. Immunol. 177 (2006) 4350-4359
7. Celli B.R., MacNee W., Agustí A.G., Anzueto A., Berg B., Buist A.S., Calverley P.M.A., Chavannes N., Dillard T., Fahy B., Fein A., Heffner J., Lareau S., Meek P., Martinez F., McNicholas W., Muris J., Austegard E., Pauwels R., Rennard S., Rossi A., Siafakas N., Tiep B., Vestbo J., Wouters E., and ZuWallack R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23 (2004) 932-946
8. Churg A., Wang R., Wang X., Onnervik P.O., Thim K., and Wright J.L. Effect of an MP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 62 (2007) 706-713
9. Cukić V., and Maglajlić J. Body weight loss in patients with chronic obstructive pulmonary disease. Med. Arh. 61 (2007) 175-181
10. Dawkins P.A., and Stockley R.A. Animal models of chronic obstructive pulmonary disease. Thorax 56 (2001) 972-977
11. Dunnill M.S. Quantitative methods in the study of pulmonary pathology. Thorax 17 (1962) 320-328
12. Finkelstein R., Fraser R.S., Ghezzo H., and Cosio M.G. Alveolar inflammation and its relation to emphysema in smokers. Am. J. Respir. Crit. Care Med. 152 (1995) 1666-1672
13. Groneberg D.A., and Chung K.F. Models of chronic obstructive pulmonary disease. Respir. Res. 5 (2004) 18
14. Guerassimov A., Hoshino M., Takubo Y., Turcotte A., Yamamoto M., Ghezzo H., Triantafillopoulos A., Whittaker K., Hoidal J.R., and Cosio M.G. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am. J. Respir. Crit. Care Med. 170 (2004) 974-980
15. He S.H., Zheng J., and Duan M.K. Induction of mucin secretion from human bronchial tissue and epithelial cells by rhinovirus and lipopolysaccharide. Acta Pharmacol. Sin. 25 (2004) 1176-1181
16. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniack R.M., Rogers R.M., Sciurba F.C., Coxson H.O., and Paré P.D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350 (2004) 2645-2653
17. James A.L., and Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur. Respir. J. 30 (2007) 134-155
18. Lang M.R., Fiaux G.W., Gillooly M., Stewart J.A., Hulmes D.J., and Lamb D. Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 49 (1994) 319-326
19. Lutchen K.R., Yang K., Kaczka D.W., and Suki B. Optimal ventilator waveforms for estimating low-frequency respiratory impedance. J. Appl. Physiol. 75 (1993) 478-488
20. Macklem P.T., Proctor D.F., and Hogg J.C. The stability of peripheral airways. Respir. Physiol. 8 (1970) 191-203
21. + T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J. Immunol. 178 (2007) 8090-8096
22. March T.H., Barr E.B., Finch G.L., Hahn F.F., Hobbs C.H., Ménache M.G., and Nikula K.J. Cigarette smoke exposure produces more evidence of emphysema in B6C3F1 mice than in F344 rats. Toxicol. Sci. 51 (1999) 289-299
23. March T.H., Wilder J.A., Esparza D.C., Cossey P.Y., Blair L.F., Herrera L.K., McDonald J.D., Campen M.J., Mauderly J.L., and Seagrave J.C. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol. Sci. 92 (2006) 545-559
24. Martorana P.A., Beume R., Lucattelli M., Wollin L., and Lungarella G. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am. J. Respir. Crit. Care Med. 172 (2005) 848-853
25. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S., and GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med 163 (2001) 1256-1276
26. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., Weel C.V., and Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176 (2007) 532-555
27. Rubio M.L., Sanchez-Cifuentes M.V., Ortega M., Peces-Barba G., Escolar J.D., Verbanck S., Paiva M., and González Mangado N. N-Acetylcysteine prevents cigarette smoke induced small airways alterations in rats. Eur. Respir. J. 15 (2000) 505-511
28. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., and Wouters E.F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am. Rev. Respir. Dis. 147 (1993) 1151-1156
29. Silva Bezerra F., Valença S.S., Lanzetti M., Pimenta W.A., Castro P., Gonçalves Koatz V.L., and Porto L.C. α-Tocopherol and ascorbic acid supplementation reduced acute lung inflammatory response by cigarette smoke in mouse. Nutrition 22 (2006) 1192-1201
30. Smith K.R., Uyeminami D.L., Kodavanti U.P., Crapo J.D., Chang L.Y., and Pinkerton K.E. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic. Biol. Med. 33 (2002) 1106-1114
31. Sørhaug S., Steinshamn S., Nilsen O.G., and Waldum H.L. Chronic inhalation of carbon monoxide: effects on the respiratory and cardiovascular system at doses corresponding to tobacco smoking. Toxicology 228 (2006) 280-290
32. Stevenson C.S., Docx C., Webster R., Battram C., Hynx D., Giddings J., Cooper P.R., Chakravarty P., Rahman I., Marwick J.A., Kirkham P.A., Charman C., Richardson D.L., Nirmala N.R., Whittaker P., and Butler K. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L1183-1193
33. Stringer K.A., Freed B.M., Dunn J.S., Sayers S., Gustafson D.L., and Flores S.C. Particulate phase cigarette smoke increases MnSOD, NQO1 and CINC-1 in rat lungs. Free Radic. Biol. Med. 37 (2004) 1527-1533
34. Van Miert E., Dumont X., and Bernard A. CC16 as a marker of lung epithelial hyperpermeability in an acute model of rats exposed to mainstream cigarette smoke. Toxicol. Lett. 159 (2005) 115-123
35. Vestbo J., Prescott E., Lange P., and Copenhagen City Heart Study Group. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am. J. Respir. Crit. Care Med. 153 (1996) 1530-1535
36. Wright J.L., Hobson J., Wiggs B.R., Paré P.D., and Hogg J.C. Effect of cigarette smoking on structure of the small airways. Lung 165 (1987) 91-100
37. Wright J.L., Postma D.S., Kerstjens H.A., Timens W., Whittaker P., and Churg A. Airway remodeling in the smoke exposed guinea pig model. Inhal. Toxicol. 19 (2007) 915-923
38. Xu L., Cai B.Q., and Zhu Y.J. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats. Chin. Med. J. (Engl.) 117 (2004) 1611-1619